Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillermo De la Cruz

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
JAMA|April 17, 2003
Clopidogrel and percutaneous coronary interventionsJavier Borja, Iñaki Pérez, Guillermo De la Cruz
Journal of Clinical Ultrasound : JCU|September 18, 2024
Accuracy of supervised measurement of fetal weight in a residency programAna Fabianne Brambila-Rodríguez, Guillermo De La Cruz Villalobos, Juan Joel Domínguez-Rodríguez, et al.
Health and Quality of Life Outcomes|January 31, 2021
Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS)Marta Benavent, Javier Sastre, Ignacio García Escobar, et al.
Endocrine|July 30, 2020
Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegalyIgnacio Bernabéu, Carmen Fajardo, Mónica Marazuela, et al.
Endocrinologia, Diabetes Y Nutricion|February 19, 2019
ACROSTART: A retrospective study of the time to achieve hormonal control with lanreotide Autogel treatment in Spanish patients with acromegalyCristina Álvarez-Escolá, Eva María Venegas-Moreno, Juan Antonio García-Arnés, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
JAMA|April 17, 2003
Clopidogrel and percutaneous coronary interventionsJavier Borja, Iñaki Pérez, Guillermo De la Cruz
Journal of Clinical Ultrasound : JCU|September 18, 2024
Accuracy of supervised measurement of fetal weight in a residency programAna Fabianne Brambila-Rodríguez, Guillermo De La Cruz Villalobos, Juan Joel Domínguez-Rodríguez, et al.
Health and Quality of Life Outcomes|January 31, 2021
Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS)Marta Benavent, Javier Sastre, Ignacio García Escobar, et al.
Endocrine|July 30, 2020
Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegalyIgnacio Bernabéu, Carmen Fajardo, Mónica Marazuela, et al.
Endocrinologia, Diabetes Y Nutricion|February 19, 2019
ACROSTART: A retrospective study of the time to achieve hormonal control with lanreotide Autogel treatment in Spanish patients with acromegalyCristina Álvarez-Escolá, Eva María Venegas-Moreno, Juan Antonio García-Arnés, et al.
Pageof 1